TScan Therapeutics, Inc.
USD0.98
-0.03 (-2.97%)
CEO
Gavin MacBeath
IPO Date
2021-07-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.99
Prev. Close
$1.01
Day Low
$0.97
Day High
$1.07
52W Low
$0.88
52W High
$2.57
Market Cap
$0.06B
Volume
0.48M
| 67,000 |
| $0.99 |
| 22 May 2026 | Nicholson Garry A | director | A-Award | Acquired | 67,000 | $0.99 |
| 22 May 2026 | Gruia Gabriela | director | A-Award | Acquired | 67,000 | $0.99 |
| 22 May 2026 | Dorton Katina | director | A-Award | Acquired | 67,000 | $0.99 |
| 22 May 2026 | Klencke Barbara | director | A-Award | Acquired | 67,000 | $0.99 |
| 22 Jan 2026 | Amello Jason | Chief Financial Officer | A-Award | Acquired | 350,000 | $1.12 |
| 22 Jan 2026 | MacBeath Gavin | director, officer: Chief Executive Officer | A-Award | Acquired | 1,165,000 | $1.12 |
| 22 Jan 2026 | Dworak Leiden | See Remarks | A-Award | Acquired | 100,000 | $1.12 |
| 22 Jan 2026 | Louis Chrystal | Chief Medical Officer | A-Award | Acquired | 420,000 | $1.12 |